back to all entries

Rep. Shontel Brown Introduces ‘HER’ Act to Investigate Chemicals in Beauty Products 

July 02,2025

Rep. Shontel Brown (D-Ohio) has introduced the Health & Endocrine Research on Personal Care Products for Women (HER) Act, a bill aimed at funding research into the link between personal care products and reproductive health issues in Black and Latina women. 

The bill would create a federal grant program to study endocrine-disrupting chemicals found in many beauty and hygiene products marketed to women of color. These chemicals have been linked to serious conditions like uterine fibroids, infertility, and cancer. 

Brown said the HER Act will raise awareness, improve consumer safety, and address racial health disparities. “There is a clear nexus between unsafe products… and the higher incidence of reproductive health issues that we experience,” she said. 

Supporters of the bill include the Endocrine Society and the American Medical Women’s Association, who say the legislation is an important step toward protecting women’s health. 

To read more about the ‘HER’ Act, click here

Other Posts

Prevalence of Fibroids and Delayed Treatment
09/23/25

Fibroids in the Spotlight: From Reality TV to Global Health Concern 

On a recent season of The Real Housewives of Beverly Hills, newcomer Bozoma Saint John spoke about her struggle with fibroids following surgery. She’s not alone—other Housewives stars have also

StudyLinksFibroidsToAtrialFibrillation
09/17/25

New Study Links Fibroids to Higher Risk of Atrial Fibrillation 

A large population study from South Korea has found that women in their 20s and 30s with uterine fibroids face a 50% higher risk of developing atrial fibrillation (AFib), a

StudyLinksHysterectomyToHigherStrokeRisk
09/17/25

Study Finds Hysterectomy May Raise Stroke Risk 

New research suggests that hysterectomy, the surgical removal of the uterus, could come with long-term risks for women’s health.  A review of data from more than two million women found